Over one million women have used the Oncotype DX test to help determine the right treatment for their early-stage breast cancer.

Not All Breast Cancers Are the Same

The Oncotype DX test provides a personalized score based on the biology of your tumor and can help tailor treatment decisions for your individual cancer. Over a million women have taken the Oncotype DX test to date. Watch the video to hear some of their stories.

With the Oncotype DX Test, Outcomes Matter

The Oncotype DX Breast Recurrence Score test is a genomic test for early-stage breast cancer that can help guide treatment decisions for the best possible outcome. Watch our Outcomes Matter video to learn more.

Patient Stories

Read personal stories of breast cancer survivors and how the
Oncotype DX test helped guide their treatment decision.